Nicotine Polacrilex Lozenge
Product Images NDC 72162-2287

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 72162-2287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (721622287extendedlabel)

This text contains important information regarding the usage of nicotine lozenges for smoking cessation. It advises users under 18 to consult a doctor before use and recommends starting the lozenge on the quit day. It suggests using a 4mg lozenge if the first cigarette is smoked within 30 minutes of waking up, and a 2mg lozenge if it is smoked more than 30 minutes after waking up. The text also provides a 12-week schedule for the frequency of using the lozenges based on the time of the first cigarette smoked.*

FDA Label Image

Wallet Card Image 1 (Image 01)

FDA Label Image

Wallet Card Image 2 (Image 02)

This text provides a list of important contact numbers for support and help related to health issues. It includes numbers for the American Lung Association, American Cancer Society, American Heart Association, and suggests reaching out to a quitting buddy or a friend who has successfully quit something. This information may be helpful for individuals seeking assistance or guidance in these areas.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

Free & Personalized Support Plan provided by IS_I okeFree Habits.com. Get the help you need to break free from your harmful habits with this tailored support plan.*

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

This text provides reminders for a step-by-step cessation plan for ex-smokers. It includes details about the recommended schedule for using lozenges to quit smoking, such as the frequency and timing. The text also references specific weeks in the quitting process where certain actions should be taken, like at the beginning of the first week and at week 7 and week 10 after the quit date.*

FDA Label Image

Label (Lbl721622287)

This description is a detailed list of drug facts and information regarding Nicotine Polacrilex Lozenges (2 mg each) for smoking cessation. It includes the purpose of the product, active and inactive ingredients, directions for use, warnings, and precautions. The text also provides details on potential allergic reactions, overdose protocols, and contact information for medical emergencies. Additionally, it offers information on the packaging, quantity, and manufacturer of the lozenges. Overall, this text serves as a helpful guide for individuals considering or currently using this smoking cessation aid.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.